PE Advent completes acquisition of Suven Pharma, appoints new Board and management team

Private equity firm Advent International has completed its majority acquisition of Indian contract development and manufacturing organisation (CDMO) Suven Pharma. Advent acquired a 50.1% stake in Suven in December 2020 for INR 6,313 crore ($866 million) and will launch an open offer for an additional 26% of the company.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/lJCz5If
via IFTTT